Biotech Values

[DewDiligence]

A comment and a quiz on the Sandoz CEO interview in #msg-52862494. First, the comment.

Sandoz and Novartis believe that there's synergy between the two sectors. The savings created by the use of cheaper drugs can be reinvested by governments or companies in development of more innovative drugs. Therefore, the relationship between the sides is very symbiotic.

A stronger reason that it makes sense for NVS to have branded and generic drugs under the same corporate umbrella is that they use the same source materials and distributions channels.

Now, the quiz: Find the factual error in the article. Although the error is small, it ought to be noticeable to investors who have been following MNTA closely.